Viemed Healthcare, Inc. (NASDAQ:VMD) Stock Has Consensus Target Price of $12.00 According to Analysts

Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) have been given a consensus recommendation of “Hold” by the five ratings firms that are covering the stock, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $12.00.

Several research analysts have weighed in on VMD shares. Wall Street Zen upgraded shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Freedom Broker decreased their target price on shares of Viemed Healthcare from $11.00 to $10.00 and set a “hold” rating for the company in a research note on Monday. Freedom Capital cut shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Weiss Ratings downgraded shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, August 17th. Finally, Barrington Research initiated coverage on shares of Viemed Healthcare in a research note on Monday, August 24th. They issued an “outperform” rating and a $14.00 price target on the stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of Viemed Healthcare in the second quarter worth about $54,587,000. Nantahala Capital Management LLC bought a new stake in shares of Viemed Healthcare during the 2nd quarter worth about $7,209,873. Punch & Associates Investment Management Inc. acquired a new position in shares of Viemed Healthcare during the 2nd quarter valued at about $6,082,000. Raffles Associates LP acquired a new position in shares of Viemed Healthcare during the 2nd quarter valued at about $4,602,000. Finally, Arrowstreet Capital Limited Partnership raised its stake in shares of Viemed Healthcare by 101.9% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock valued at $6,550,000 after acquiring an additional 358,863 shares in the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Stock Down 2.2%

NASDAQ:VMD traded down $0.20 on Monday, hitting $8.93. 285,977 shares of the company’s stock traded hands, compared to its average volume of 284,811. The company has a market cap of $338.38 million, a PE ratio of 23.50, a price-to-earnings-growth ratio of 2.21 and a beta of 1.05. Viemed Healthcare has a 1 year low of $6.18 and a 1 year high of $12.61. The company has a current ratio of 1.25, a quick ratio of 1.16 and a debt-to-equity ratio of 0.05. The firm has a 50-day moving average price of $9.26 and a 200-day moving average price of $9.59.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The company had revenue of $80.67 million during the quarter, compared to analysts’ expectations of $80.78 million. Viemed Healthcare had a return on equity of 10.64% and a net margin of 5.03%. Equities analysts anticipate that Viemed Healthcare will post 0.41 EPS for the current fiscal year.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.

The company’s offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.